Page 5 - Optune Lua News Today

NovoCure Limited (NASDAQ:NVCR – Free Report) – Leerink Partnrs decreased their FY2023 earnings estimates for shares of NovoCure in a report issued on Tuesday, November 28th. Leerink Partnrs analyst J. Chang now forecasts that the medical equipment provider will earn ($2.07) per share for the year, down from their prior estimate of ($2.00). The consensus […]

NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2024 EPS estimates for shares of NovoCure in a note issued to investors on Tuesday, November 28th. Leerink Partnrs analyst J. Chang expects that the medical equipment provider will post earnings per share of ($0.45) for the quarter. Leerink Partnrs […]

NovoCure (NASDAQ:NVCR – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Risk and Volatility NovoCure has a beta of […]

StockNews.com upgraded shares of NovoCure (NASDAQ:NVCR – Free Report) from a sell rating to a hold rating in a research note published on Friday. Several other research firms have also issued reports on NVCR. Wells Fargo & Company dropped their price objective on NovoCure from $102.00 to $49.00 and set an overweight rating on the […]

NovoCure Limited (NASDAQ:NVCR – Get Free Report) shares rose 7.2% during mid-day trading on Monday . The stock traded as high as $15.24 and last traded at $15.24. Approximately 445,283 shares were traded during mid-day trading, a decline of 68% from the average daily volume of 1,394,237 shares. The stock had previously closed at $14.21. […]

NovoCure Limited (NASDAQ:NVCR – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 7,580,000 shares, a drop of 17.7% from the August 31st total of 9,210,000 shares. Based on an average daily trading volume, of 1,760,000 shares, the short-interest ratio […]

NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The […]

HC Wainwright lowered shares of NovoCure (NASDAQ:NVCR – Free Report) from a buy rating to a neutral rating in a report issued on Monday morning, MarketBeat.com reports. HC Wainwright currently has $25.00 target price on the medical equipment provider’s stock, down from their prior target price of $85.00. HC Wainwright also issued estimates for NovoCure’s […]

NovoCure (NASDAQ:NVCR – Get Free Report) had its price target decreased by equities researchers at Wells Fargo & Company from $102.00 to $49.00 in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price target indicates a potential upside of […]

-- Health care stocks were steady to higher late Monday afternoon with the NYSE Health Care Index adding 0.1% and the Health Care Select Sector SPDR Fund little changed. The iShares Biotechnology...